These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 21651427

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 4. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC, Lau H, La HO, Choi IS, Geba GP.
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [Abstract] [Full Text] [Related]

  • 5. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS, Yawn BP.
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP.
    Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 15. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH.
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [Abstract] [Full Text] [Related]

  • 20. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, Frost FJ.
    Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.